Hepatitis G virus: A suitable marker of in vivo efficacy for pathogen inactivation

Vox Sanguinis

Volumn 95, Issue 1, 2008, Pages 76-78

  Lefrere J J ^a   Laperche, S ^a   Roudot Thoraval, F ^b  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Hepatitis G virus; Pathogen inactivation; Transfusion safety

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; PRIORITY JOURNAL; SCREENING; TORQUE TENO VIRUS; VIRUS TRANSMISSION;

BIOLOGICAL MARKERS; BLOOD TRANSFUSION; GB VIRUS C; HUMANS; QUALITY CONTROL; VIRUS INACTIVATION;

EID: 44849139795     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2008.01050.x     Document Type: Article

References (13)

1. Singh Y, Sawyer LS, Pinkoski LS, Dupuis KW, Hsu JC, Lin L, Corash L:photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation functium. Transfusion 2006 46:1168 1177
2. Borgherini G, Poubeau P, Staikowski F, Lory M, Le Moullec N, Becquart JP, Wengling C, Michault A, Paganin F:Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis 2007 44:1401 1407
3. Kriebel D, Tickner J, Epstein P, Lemons J, Levins R, Loechler EL, Quinn M, Rudel R, Schettler T, Stoto M:The precautionary principle in environmental science. Environ Health Perspect 2001 109:871 876
4. Pillonel J, Laperche S:Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT). Euro Surveill 2005 1:10
5. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH, NHLBI-REDS NAT Study Group:A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005 45:254 264
6. Simons N, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK:Isolation of a novel virus-like sequences associated with human hepatitis. Nature Med 1995 1:564 569
7. Tazke M, Kiyosawa K, Stark K, Schlueter V, Ofenloch-Haehnle B, Hess G, Engel AM:Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997 349:318 320
8. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JW, Kim JP:The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997 336:747 754
9. Lefrere JJ, Roudot-Thoraval F, Morand-Joubert L, Brossard Y, Parnet-Mathieu F, Mariotti M, Agis F, Rouet G, Lerable J, Lefèvre G, Girot R, Loiseau P:Prevalences of GBV-C/Hepatitis G virus (HGV) RNA and of anti-E2 antibody in individuals at high risk or low risk of blood-borne or sexually-transmitted viruses: evidence of sexual and parenteral transmission. Transfusion 1999 39:83 93
10. Lefrere JJ, Loiseau P, Maury J, Lasserre J, Mariotti M, Ravera N, Lerable J, Lefèvre G, Morand-Joubert L, Girot R:Natural history of GBV-C/hepatitis G virus (HGV) infection through the follow-up of GBV-C/HGV-infected blood donors and recipients studied by RNA PCR and anti-E2 serology. Blood 1997 90:3776 3780
11. Lefrere JJ, Ferec C, Roudot-Thoraval F, Loiseau P, Cantaloube JF, Biagini P, Mariotti M, LeGac G, Mercier B:GBV-C/Hepatitis G virus (HGV) RNA in immunodeficient individuals and in immunocompetent individuals. J Virol Methods 1999 59:32 37
12. Simmonds P, Davidson F, Lycett C, Prescott LE, MacDonald DM, Ellender J, Yap PL, Ludlam CA, Haydon GH, Gillon J, Jarvis LM:Detection of a novel DNA virus (TT virus) in blood donors and blood products. Lancet 1998 352:191 195
13. BruchMûller I, Janetzko K, Bugert P, Mayaudon V, Corash L, Lin L, Kiüter H:Polymerase chain reaction inhibition assay documenting the amotosalen-based photochemical pathogen inactivation process of platelet concentrates. Transfusion 2005 45:1464 1472